Search

Garry John Southan

from Swampscott, MA
Age ~64
Get Report
Also known as:
Garry J Southan, John Southan, Garry Sothern
Phone and address:
18 Nirvana Dr, Swampscott, MA 01907
(781) 593-6268
Connected to:
Adam G Southam, 59Alice D Southall, 60Amanda K Southall, 36Andrew W Southam, 62Ben T Southammavong, 55Celynna J Southall, 63Charlotte A Southall, 66Courtney Southall, 44Ellen P Southall, 75Joe R Southall, 65

Garry Southan Phones & Addresses

  • 18 Nirvana Dr, Swampscott, MA 01907 (781) 593-6268
  • 18 Nirvana Dr APT 7A, Swampscott, MA 01907
  • 295 Lynn Shore Dr, Lynn, MA 01902 (781) 593-6268
  • Salem, MA
  • Cincinnati, OH
  • Frederick, MD
  • Beverly, MA

Business Records

Name / Title
Company / Classification
Phones & Addresses
Garry Southan
Senior Vice-President, Director, Executive Vice-President, Senior Vice-president, Executive Vice President Principal Fellow AndOf The Board Of Directors
Inotek Pharmaceuticals
Pharmaceuticals · Nonclassifiable Establishments · Whol Drugs/Sundries · Mfg Pharmaceutical Preparations · Commercial Physical Research · Druggists' Goods Merchant Whols · Nonclassified Establishments
33 Hayden Avenue, 2, Lexington, MA 02421
131 Hartwell Ave, Lexington, MA 02421
33 Hayden Ave, Lexington, MA 02421
100 Cummings Ctr, Beverly Farms, MA 01915
(978) 232-9660, (978) 232-8975, (978) 927-5124

Publications

Us Patents

Substituted Phenanthridinones And Methods Of Use Thereof

View page
US Patent:
6476048, Nov 5, 2002
Filed:
Jun 22, 2000
Appl. No.:
09/602539
Inventors:
Csaba Szabo - Gloucester MA
Prakash Jagtap - Beverly MA
Garry Southan - Salem MA
Andrew Salzman - Belmont MA
Assignee:
Inotek Pharamaceuticals Corporation - Beverly MA
International Classification:
A61K 31473
US Classification:
514309, 514319, 514331, 514298, 546141, 546146, 546143, 546108
Abstract:
This invention provides a novel class of substituted 6(5H)phenanthridinone compounds. Pharmaceutical compositions, and methods of making and using the compounds, or a pharmaceutically acceptable salt, hydrate, prodrug, or mixture thereof are also described.

Methods For The Treatment Of Neurodegenerative Disorders Using Substituted Phenanthridinone Derivatives

View page
US Patent:
6531464, Mar 11, 2003
Filed:
Jun 29, 2000
Appl. No.:
09/606587
Inventors:
Csaba Szabo - Gloucester MA
Prakash Jagtap - Beverly MA
Garry Southan - Salem MA
Andrew Salzman - Belmont MA
Assignee:
Inotek Pharmaceutical Corporation - Beverly MA
International Classification:
A61K 3133
US Classification:
514183, 514309, 514310, 514319, 514331, 546141, 546143
Abstract:
This invention provides a novel class of substituted 6(5H)phenanthridinone compounds. The invention also includes pharmaceutical compositions, and methods of making and using the compounds, or a pharmaceutically acceptable salt, hydrate, prodrug, or mixture thereof. Methods of using the compounds and pharmaceutical compositions for treating neurodegenerative disorders, such as multiple sclerosis are also described.

7-Substituted Isoindolinone Inhibitors Of Inflammation And Reperfusion Injury And Methods Of Use Thereof

View page
US Patent:
6534651, Mar 18, 2003
Filed:
Jan 19, 2001
Appl. No.:
09/766053
Inventors:
Prakash Jagtap - Beverly MA
Garry Southan - Salem MA
Andrew Salzman - Belmont MA
Csaba Szabo - Gloucester MA
Siya Ram - Beverly MA
Assignee:
Inotek Pharmaceuticals Corp. - Beverly MA
International Classification:
C07D41312
US Classification:
544144, 544544, 544277, 544310, 544312, 544373, 544546, 544146, 544165, 544200, 5442771, 544548, 54430511, 5443121, 544253, 544467, 544472
Abstract:
The invention provides a novel class of substituted isoindolinone derivatives, useful for the treatment of inflammation and reperfusion injuries. Pharmaceutical compositions, and methods of making and using the compounds, or pharmaceutically acceptable salts, hydrates, stereoisomers or mixtures thereof are also described. The novel isoindolinone derivatives have the formula: or a pharmaceutically acceptable base or acid addition salt, hydrate, stereoisomer, or mixtures thereof, wherein R is described herein.

Nucleoside Compounds And Compositions Thereof

View page
US Patent:
6903079, Jun 7, 2005
Filed:
Dec 16, 2002
Appl. No.:
10/320780
Inventors:
Prakash Jagtap - Beverly MA, US
Garry Southan - Salem MA, US
Andrew Salzman - Belmont MA, US
Csaba Szabo - Gloucester MA, US
Siya Ram - Winchester MA, US
Assignee:
Inotek Pharmaceuticals Corporation - Beverly MA
International Classification:
C07H019/167
A61K031/7076
US Classification:
514 45, 514 46, 536 2722, 536 273, 536 276, 536 2762, 536 278
Abstract:
The invention provides a novel class of substituted nucleoside derivatives having the formula:A-Z1-L-Z2-Gwherein:Pharmaceutical compositions, and methods of making and using the compounds, or pharmaceutically acceptable salts, hydrates, or mixtures thereof are also described.

5-Aryltetrazole Compounds, Compositions Thereof, And Uses Therefor

View page
US Patent:
7078423, Jul 18, 2006
Filed:
Jul 18, 2002
Appl. No.:
10/197609
Inventors:
Alex Nivorozhkin - West Roxbury MA, US
John Van Duzer - Georgetown MA, US
Andrew Salzman - Belmont MA, US
Garry Southan - Lynn MA, US
Siya Ram - Winchester MA, US
Qi Zeng - North Andover MA, US
Csaba Szabo - Gloucester MA, US
Assignee:
Inotek Pharmaceuticals Corporation - Beverly MA
International Classification:
A61K 31/41
C07D 257/04
US Classification:
514381, 548253
Abstract:
The present invention relates to 5-Aryltetrazole compounds, compositions comprising a 5-Aryltetrazole compound, and methods for treating an inflammation disease, a reperfusion disease, hyperuricemia, gout, or tumor-lysis syndrome in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.

Aryltetrazole Compounds, And Compositions Thereof

View page
US Patent:
7087631, Aug 8, 2006
Filed:
Jul 17, 2003
Appl. No.:
10/620619
Inventors:
Alex Nivorozhkin - West Roxbury MA, US
John Van Duzer - Georgetown MA, US
Garry Southan - Lynn MA, US
Siya Ram - Winchester MA, US
Qi Zeng - North Andover MA, US
Assignee:
Inotek Pharmaceuticals Corporation - Beverly MA
International Classification:
A61K 31/41
C07D 257/04
US Classification:
514381, 548253
Abstract:
The present invention relates to 5-Aryltetrazole Compounds, compositions comprising an effective amount of a 5-Aryltetrazole Compound, and methods for treating an inflammation disease, a reperfusion disease, or hyperuricemia in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.

5-Aryltetrazole Compounds And Uses Thereof

View page
US Patent:
7135491, Nov 14, 2006
Filed:
Jan 6, 2005
Appl. No.:
11/030536
Inventors:
Alex Nivorozhkin - West Roxbury MA, US
John Van Duzer - Georgetown MA, US
Andrew Salzman - Belmont MA, US
Garry Southan - Lynn MA, US
Siya Ram - Winchester MA, US
Qi Zeng - North Andover MA, US
Csaba Szabo - Gloucester MA, US
Assignee:
Inotek Pharmaceuticals Corp. - Beverly MA
International Classification:
A61K 31/41
US Classification:
514381
Abstract:
The present invention relates to 5-Aryltetrazole Compounds, compositions comprising an effective amount of a a 5-Aryltetrazole Compound, and methods for treating an inflammation disease, a reperfusion disease, or hyperuricemia in an animal in need thereof comprising administering to the animal an effective amount of a 5-Aryltetrazole compound.

Pyridyl-Substituted Porphyrin Compounds And Methods Of Use Thereof

View page
US Patent:
7432369, Oct 7, 2008
Filed:
Mar 25, 2005
Appl. No.:
11/090447
Inventors:
William Williams - Ipswich MA, US
Garry Southan - Lynn MA, US
Assignee:
Inotek Pharmaceuticals Corporation - Beverly MA
International Classification:
C07B 47/00
C07D 487/22
US Classification:
540145
Abstract:
The present invention relates to Pyridyl-Substituted Porphyrin Compounds, compositions comprising an effective amount of a Pyridyl-Substituted Porphyrin Compound and methods for treating or preventing injury due to exposure to a reactive species, erectile dysfunction due to surgery, lung disease, hyperoxia, neurodegenerative disease, liver disease, myocardial damage during cardioplegia, an inflammatory condition, a reperfusion injury, an ischemic condition, a cardiovascular disease, diabetes, a diabetic complication, cancer, a side effect of cancer chemotherapy, or a radiation-induced injury, or to prolong the half-life of an oxidation-prone compound, comprising administering to a subject in need thereof an effective amount of a Pyridyl-Substituted Porphyrin Compound.
Control profile
Garry John Southan from Swampscott, MA, age ~64 Get Report